ARWR — Arrowhead Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Arrowhead Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2019 September 30th	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	259	315	368	376	396
Net Total Accounts Receivable
Net Total Receivables	0.661	0.846	10.3	1.41	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	265	322	385	405	420
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23.2	47	66	169	336
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	350	523	710	692	766
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	97.1	40.7	147	139	105
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	105	60.7	301	293	494
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	245	462	409	399	271
Total Liabilities & Shareholders' Equity	350	523	710	692	766
Total Common Shares Outstanding